Source:http://linkedlifedata.com/resource/pubmed/id/15544842
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
2004-11-16
|
pubmed:abstractText |
Insulin-like growth factor (IGF)-1 appears to play an important role in cardiac hypertrophy or remodeling. However, the role of endogenous IGF-1 in the growth of cardiac myocytes and fibroblasts remains unclear. This study investigated the major site of the production of cardiac IGF-1 and the local effects of endogenous IGF-1 secreted from cardiac cells. A significant expression of IGF-1 mRNA was found in cultured neonatal and adult rat cardiac fibroblasts, but not in myocytes. In addition, an in vivo examination by in situ hybridization histochemical analyses demonstrated the IGF-1 transcripts in the interstitial fibrotic tissue of the ventricle. Time-dependent secretion of IGF-1 protein was also observed in cultured cardiac fibroblasts. An antibody against IGF-1 decreased collagen synthesis in cardiac fibroblasts under basal conditions. Fibroblast-conditioned medium, as well as exogenous IGF-1, increased protein synthesis in cardiac myocytes, and this increase was inhibited by antibodies against IGF-1 and IGF-1 receptor, IGF binding protein-3, and IGF-1 receptor antagonist. These observations suggest that IGF-1 is produced and released mainly from cardiac fibroblasts and that endogenous IGF-1 promotes collagen synthesis by cardiac fibroblasts and hypertrophy of myocytes as an autocrine and a paracrine factor. Cardiac IGF-1 may function as an endogenous modulator of cardiac hypertrophy or remodeling.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Jan
|
pubmed:issn |
0167-0115
|
pubmed:author |
pubmed-author:HorioTakeshiT,
pubmed-author:KangawaKenjiK,
pubmed-author:KawanoYuheiY,
pubmed-author:KishimotoIchiroI,
pubmed-author:MakiToshiyukiT,
pubmed-author:OkumuraHiroyukiH,
pubmed-author:SugaShin-ichiS,
pubmed-author:TakeoSatoshiS,
pubmed-author:TokudomeTakeshiT,
pubmed-author:YoshiharaFumikiF
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
124
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
65-72
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15544842-Animals,
pubmed-meshheading:15544842-Animals, Newborn,
pubmed-meshheading:15544842-Antibodies,
pubmed-meshheading:15544842-Autocrine Communication,
pubmed-meshheading:15544842-Cell Size,
pubmed-meshheading:15544842-Cells, Cultured,
pubmed-meshheading:15544842-Dose-Response Relationship, Drug,
pubmed-meshheading:15544842-Fibroblasts,
pubmed-meshheading:15544842-Gene Expression Regulation,
pubmed-meshheading:15544842-Insulin-Like Growth Factor I,
pubmed-meshheading:15544842-Muscle Cells,
pubmed-meshheading:15544842-Myocardium,
pubmed-meshheading:15544842-Paracrine Communication,
pubmed-meshheading:15544842-Rats,
pubmed-meshheading:15544842-Rats, Wistar
|
pubmed:year |
2005
|
pubmed:articleTitle |
Production and autocrine/paracrine effects of endogenous insulin-like growth factor-1 in rat cardiac fibroblasts.
|
pubmed:affiliation |
Division of Hypertension and Nephrology, Department of Medicine, National Cardiovascular Center, 5-7-1, Fujishirodai, Suita, Osaka 565-8565, Japan. thorio@ri.ncvc.go.jp
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|